Bank Of New York Mellon Corp Night Hawk Biosciences, Inc. Transaction History

Bank Of New York Mellon Corp

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 14, 2023	BUY	$0.77 - $1.62 $11,238 - $23,645	14,596 New	14,596 $11,000
Q1 2021 May 13, 2021	SELL	$5.67 - $12.54 $8,612 - $19,048	-1,519 Reduced 9.43%	14,596 $106,000
Q4 2020 Feb 09, 2021	BUY	$5.28 - $9.59 $85,087 - $154,542	16,115 New	16,115 $86,000

48.5K

Ticker NHWK
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,661,500
Market Cap $4.11M
Description
NightHawk Biosciences, Inc., an integrated biopharmaceutical company, engages in the development of immune therapies and vaccines. The company's therapies are used to modulate the immune system against various diseases, including cancer and infectious diseases. Its gp96 platform, including ImPACT, an allogenic cell-based, T-cell-stimulating plat...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.